Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease. PMID: 35039796 Journal: BMJ open ophthalmology Year: 2022 Reference: BMJ Open Ophthalmol. 2022 Jan 11;7(1):e000867. doi: 10.1136/bmjophth-2021-000867. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Aragon, David; Azarfane, Brahim; Banderas Garcia, Sandra; Garcia-Arumi, Jose; Garrell-Salat, Xavier; Otero-Romero, Susana; Sanchez-Montalva, Adrian; Trejo, Fernando; Zapata, Miguel Angel et al. DOI: 10.1136/bmjophth-2021-000867 Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. PMID: 34115832 Journal: RHEUMATOLOGY Year: 2022 Reference: Rheumatology (Oxford). 2022 Mar 2;61(3):1053-1061. doi: 10.1093/rheumatology/keab475. Impact factor: 7.58 Publication type: Paper in international publication Authors: Pardos-Gea, Jose, Marques-Soares, Joana R, Bujan, Segundo, Ordi-Ros, Jose, Alijotas-Reig, Jaume et al. DOI: 10.1093/rheumatology/keab475 Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. PMID: 34115832 Journal: RHEUMATOLOGY Year: 2022 Reference: Rheumatology (Oxford). 2022 Mar 2;61(3):1053-1061. doi: 10.1093/rheumatology/keab475. Impact factor: Publication type: Paper in international publication Authors: Alijotas-Reig, Jaume; Bujan, Segundo; Marques-Soares, Joana R; Ordi-Ros, Jose; Pardos-Gea, Jose et al. DOI: 10.1093/rheumatology/keab475 Personalized Surgery Service in a Tertiary Hospital: A Method to Increase Effectiveness, Precision, Safety and Quality in Maxillofacial Surgery Using Custom-Made 3D Prostheses and Implants. PMID: 36013033 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 Aug 16;11(16). pii: jcm11164791. doi: 10.3390/jcm11164791. Impact factor: Publication type: Paper in international publication Authors: Bescos-Atin, Coro; de-Pablo-Garcia-Cuenca, Alba; Masnou-Pratdesaba, Joan; Pamias-Romero, Jorge; Pujol-Pina, Rosa; Saez-Barba, Manel; Sala-Cunill, Anna; Siurana-Montilva, Sahyly; Valls-Comamala, Victoria et al. DOI: 10.3390/jcm11164791 Perspectives toward the development of advanced materials based on bacterial polysaccharides. PMID: 35770400 Journal: CURRENT MEDICINAL CHEMISTRY Year: 2022 Reference: Curr Med Chem. 2022 Jun 29. pii: CMC-EPUB-124889. doi: 10.2174/0929867329666220629152008. Impact factor: 4.53 Publication type: Paper in international publication Authors: Rafael, Diana; Marican, Adolfo; Duran-Lara, Esteban F; Vijayakumar, Sekar et al. DOI: 10.2174/0929867329666220629152008 Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018. PMID: 35447067 Journal: EMERGING INFECTIOUS DISEASES Year: 2022 Reference: Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958. Impact factor: 6.883 Publication type: Paper in international publication Authors: Mir-Cros, Alba, Moreno-Mingorance, Albert, Martin-Gomez, M Teresa, Abad, Raquel, Bloise, Ivan, Campins, Magda, Gonzalez-Praetorius, Alejandro, Gutierrez, M Nieves, Martin-Gonzalez, Hector, Munoz-Almagro, Carmen et al. DOI: 10.3201/eid2805.211958 Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018. PMID: 35447067 Journal: EMERGING INFECTIOUS DISEASES Year: 2022 Reference: Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958. Impact factor: Publication type: Paper in international publication Authors: Abad, Raquel; Bloise, Ivan; Campins, Magda; de Pablos, Manuela; Gonzalez-Lopez, Juan Jose; Gonzalez-Praetorius, Alejandro; Gutierrez, M Nieves; Larrosa, M Nieves; Martin-Gomez, M Teresa; Martin-Gonzalez, Hector et al. DOI: 10.3201/eid2805.211958 Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. PMID: 34092059 Journal: HAEMATOLOGICA Year: 2022 Reference: Haematologica. 2022 Apr 1;107(4):887-898. doi: 10.3324/haematol.2021.278990. Impact factor: 9.941 Publication type: Paper in international publication Authors: Tovy, Ayala, Rosas, Carina, Gaikwad, Amos S, Medrano, Geraldo, Zhang, Linda, Reyes, Jaime M, Huang, Yung-Hsin, Arakawa, Tastuhiko, Kurtz, Kristen, Conneely, Shannon E et al. DOI: 10.3324/haematol.2021.278990 Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. PMID: 34092059 Journal: HAEMATOLOGICA Year: 2022 Reference: Haematologica. 2022 Apr 1;107(4):887-898. doi: 10.3324/haematol.2021.278990. Impact factor: Publication type: Paper in international publication Authors: Aguilar, Rogelio; Arakawa, Tastuhiko; Brunetti, Lorenzo; Carter, Melissa T; Chen, Chun-Wei; Conneely, Shannon E; Gaikwad, Amos S; Gao, Anne; Goodell, Margaret A; Guzman, Anna G et al. DOI: 10.3324/haematol.2021.278990 Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast percentage AML. PMID: 35728048 Journal: Blood Advances Year: 2022 Reference: Blood Adv. 2022 Jun 21. pii: 485649. doi: 10.1182/bloodadvances.2022007334. Impact factor: 6.799 Publication type: Paper in international publication Authors: Ades, Lionel, Girshova, Larisa, Doronin, Vadim A, Diez-Campelo, Maria, Valcarcel, David, Kambhampati, Suman, Viniou, Nora-Athina, Woszczyk, Dariusz, De Paz Arias, Raquel, Symeonidis, Argiris et al. DOI: 10.1182/bloodadvances.2022007334 Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast percentage AML. PMID: 35728048 Journal: Blood Advances Year: 2022 Reference: Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334. Impact factor: Publication type: Paper in international publication Authors: Ades, Lionel; Anagnostopoulos, Achilles; De Paz Arias, Raquel; Diez-Campelo, Maria; Doronin, Vadim A; Faller, Douglas V; Fram, Robert J; Friedlander, Sharon; Girshova, Larisa; Kambhampati, Suman et al. DOI: 10.1182/bloodadvances.2022007334 Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease. PMID: 35676823 Journal: CLINICAL INFECTIOUS DISEASES Year: 2022 Reference: Clin Infect Dis. 2022 Jun 9. pii: 6604409. doi: 10.1093/cid/ciac453. Impact factor: 9.079 Publication type: Paper in international publication Authors: Davidson, Rebecca M, Cohen, Keira A, Whitney Brown, A, Belessis, Yvonne, Jacobs-Sera, Deborah, Freeman, Krista G, Cristinziano, Madison, Smith, Bailey E, Dedrick, Rebekah M, van Duin, David et al. DOI: 10.1093/cid/ciac453 Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections. PMID: 36358184 Journal: Antibiotics-Basel Year: 2022 Reference: Antibiotics (Basel). 2022 Nov 1;11(11). pii: antibiotics11111528. doi: 10.3390/antibiotics11111528. Impact factor: Publication type: Paper in international publication Authors: Avgeropoulou, Stavrina; Christodoulou, Eirini; Dokoumetzidis, Aristides; Koutsoukou, Antonia; Kyriakoudi, Anna; Markantonis, Sophia L; Moraitou, Eleni; Neroutsos, Efthymios; Pontikis, Konstantinos; Rello, Jordi et al. DOI: 10.3390/antibiotics11111528 Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer. PMID: 36582117 Journal: Expert Opinion on Drug Metabolism & Toxicology Year: 2022 Reference: Expert Opin Drug Metab Toxicol. 2022 Nov;18(11):755-767. doi: 10.1080/17425255.2022.2160316. Epub 2022 Dec 29. Impact factor: Publication type: Paper in international publication Authors: Baraibar, Iosune; Elez, Elena; Gomez, Diego; Lopez, Daniel; Ros, Javier; Ros, Javier; Salva, Francesc; Saoudi Gonzalez, Nadia; Tabernero, Josep et al. DOI: 10.1080/17425255.2022.2160316 Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation. PMID: 35159859 Journal: Nanomaterials Year: 2022 Reference: Nanomaterials (Basel). 2022 Feb 1;12(3). pii: nano12030511. doi: 10.3390/nano12030511. Impact factor: 5.076 Publication type: Paper in international publication Authors: Manova, Alena; Bastus, Neus G; Moriones, Oscar H; Kohl, Yvonne; Dusinska, Maria; Runden-Pran, Elise; Puntes, Victor; Nelson, Andrew; Gabelova, Alena; Simon, Peter et al. DOI: 10.3390/nano12030511 Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation. PMID: 35159859 Journal: Nanomaterials Year: 2022 Reference: Nanomaterials (Basel). 2022 Feb 1;12(3). pii: nano12030511. doi: 10.3390/nano12030511. Impact factor: Publication type: Paper in international publication Authors: Bastus, Neus G; Dubaj, Tibor; Dusinska, Maria; Gabelova, Alena; Kohl, Yvonne; Kozics, Katarina; Manova, Alena; Moriones, Oscar H; Nelson, Andrew; Puntes, Victor et al. DOI: 10.3390/nano12030511 Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. PMID: 35965052 Journal: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA Year: 2022 Reference: Immunol Allergy Clin North Am. 2022 Aug;42(3):657-669. doi: 10.1016/j.iac.2022.05.002. Impact factor: Publication type: Review in international publication Authors: Hanania, Nicola A; Miravitlles, Marc et al. DOI: 10.1016/j.iac.2022.05.002 Pharmacotherapeutic interventions for the treatment of bacterial prostatitis. PMID: 35574695 Journal: EXPERT OPINION ON PHARMACOTHERAPY Year: 2022 Reference: Expert Opin Pharmacother. 2022 Jun 27:1-11. doi: 10.1080/14656566.2022.2077101. Impact factor: 3.889 Publication type: Review in international publication Authors: Marquez-Algaba, Ester, Burgos, Joaquin, Almirante, Benito et al. DOI: 10.1080/14656566.2022.2077101 Pharmacotherapeutic interventions for the treatment of bacterial prostatitis. PMID: 35574695 Journal: EXPERT OPINION ON PHARMACOTHERAPY Year: 2022 Reference: Expert Opin Pharmacother. 2022 Jun;23(9):1091-1101. doi: 10.1080/14656566.2022.2077101. Epub 2022 Jun 27. Impact factor: Publication type: Review in international publication Authors: Almirante, Benito; Burgos, Joaquin; Marquez-Algaba, Ester et al. DOI: 10.1080/14656566.2022.2077101 Pharmacotherapeutic management of advanced therapy drugs. PMID: 35379101 Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H Year: 2022 Reference: Farm Hosp. 2022 Jan 27;46(2):88-95. Impact factor: 0 Publication type: Paper in international publication Authors: Poveda-Andres, Jose Luis, Ruiz-Caldes, Maria Jose, Carrera-Soler, Maria Jose, Clopes-Estela, Ana, Flores-Moreno, Sandra, Garcia-Pellicer, Javier, Giraldez-Quiroga, Miriam, Lopez-Briz, Eduardo, Lozano-Blazquez, Ana, Megias-Vericat, Juan Eduardo et al. DOI: 10.7399/fh.13036 Pharmacotherapeutic management of advanced therapy drugs. PMID: 35379101 Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H Year: 2022 Reference: Farm Hosp. 2022 Jan 27;46(2):88-95. Impact factor: Publication type: Paper in international publication Authors: Carrera-Soler, Maria Jose; Clopes-Estela, Ana; Flores-Moreno, Sandra; Garcia-Pellicer, Javier; Giraldez-Quiroga, Miriam; Lopez-Briz, Eduardo; Lozano-Blazquez, Ana; Megias-Vericat, Juan Eduardo; Poveda-Andres, Jose Luis; Ruiz-Caldes, Maria Jose et al. DOI: 10.7399/fh.13036 Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study. PMID: 35205662 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 12;14(4). pii: cancers14040915. doi: 10.3390/cancers14040915. Impact factor: 6.639 Publication type: Paper in international publication Authors: Poveda, Andres, Lopez-Reig, Raquel, Oaknin, Ana, Redondo, Andres, Rubio, Maria Jesus, Guerra, Eva, Farinas-Madrid, Lorena, Gallego, Alejandro, Rodriguez-Freixinos, Victor, Fernandez-Serra, Antonio et al. DOI: 10.3390/cancers14040915 Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study. PMID: 35205662 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 12;14(4). pii: cancers14040915. doi: 10.3390/cancers14040915. Impact factor: Publication type: Paper in international publication Authors: Farinas-Madrid, Lorena; Fernandez-Serra, Antonio; Gallego, Alejandro; Guerra, Eva; Juan, Oscar; Lopez-Guerrero, Jose A; Lopez-Reig, Raquel; Oaknin, Ana; Poveda, Andres; Redondo, Andres et al. DOI: 10.3390/cancers14040915 Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. PMID: 35921760 Journal: ESMO Open Year: 2022 Reference: ESMO Open. 2022 Aug;7(4):100530. doi: 10.1016/j.esmoop.2022.100530. Epub 2022 Jul 31. Impact factor: Publication type: Paper in international publication Authors: Anido, J; Borazanci, E; Brana, I; Garralda, E; Giblin, P; Hallett, R M; Hilbert, J; Hoff, D V; Hoffman, K; Hua, F et al. DOI: 10.1016/j.esmoop.2022.100530 Pagination First page « First Previous page ‹ Previous … Page 237 Page 238 Page 239 Page 240 Current page 241 Page 242 Page 243 Page 244 Page 245 … Next page Next › Last page Last »
